Balance Sheet

Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Short-Term Debt issuances Short-Term Debt repayments

Growth Metrics

Cirtran (CIRX) Capital Expenditures (2021)

Cirtran filings provide 1 years of Capital Expenditures readings, the most recent being $2174.0 for Q4 2021.

On a quarterly basis, Capital Expenditures changed N/A to $2174.0 in Q4 2021 year-over-year; TTM through Dec 2023 was $2174.0, a N/A change, with the full-year FY2023 number at $8414.0, changed N/A from a year prior.
Capital Expenditures hit $2174.0 in Q4 2021 for Cirtran, up from $1624.0 in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $2174.0 in Q4 2021 to a low of $1624.0 in Q1 2021.